Cristal Therapeutics completes venture financing

On Jan. 19, nanomedicine company Cristal Therapeutics (Maastricht, the Netherlands) raised €12.8 million ($13.6 million) in a venture round led by Aglaia Biomedical Ventures and Droia Oncology Venture...